Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73
United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026

What the insiders did Net selling

By person

20 insiders · 19 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Esther Cho
Chief Legal Officer
—
$123.73K (2)
−$123.73K
35,770
$368.43K
−20.5%
Jasbir Seehra
Chief Executive Officer
—
$113.43K (1)
−$113.43K
440,708
$4.54M
+74.3%
Lorena Raquel Lerner
Chief Scientific Officer
—
$100.04K (2)
−$100.04K
27,559
$283.86K
−21.3%
Keith Regnante
Chief Financial Officer
—
$77.48K (1)
−$77.48K
39,261
$404.39K
—
Jean Jacques Bienaime
Director
$75.77K (6)
—
+$75.77K
19,592
$201.80K
+9,696%
Nima Farzan
Director
—
$28.17K (1) scheduled
−$28.17K
9,767
$100.60K
—
Julius Knowles
Director
—
$28.17K (1) scheduled
−$28.17K
113,191
$1.17M
−73.4%
Alpna Seth
Director
—
$28.14K (1) scheduled
−$28.14K
9,767
$100.60K
—
Annita Tanini
Corp. Controller & VP, Finance
—
$12.59K (1)
−$12.59K
45,144
$464.98K
−2.6%
Charles W. Newton
Director
—
$11.20K (2) scheduled
−$11.20K
12,114
$124.77K
—
Christopher Rovaldi
Chief Operating Officer
—
—
—
60,000
$618.00K
—
Carl L Gordon
Director
—
—
—
50,307
$518.16K
−80.6%
Orbimed Advisors LLC entity
Director
—
—
—
45,057
$464.09K
−82.6%
Yung H. Chyung
Chief Medical Officer
—
—
—
44,000
$453.20K
—
Anne Prener
Director
—
—
—
13,786
$142.00K
—
Mary Ann Gray
Director
—
—
—
12,392
$127.64K
—
Ran Nussbaum
Director
—
—
—
5,250
$54.08K
—
Tomer Kariv
Director
—
—
—
5,250
$54.08K
—
Pontifax Management 4 G.P. (2015) Ltd. entity
10% owner
—
—
—
0
$0.00
−100.0%
ADAR1 Capital Management, LLC entity
10% owner
—
—
—
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 19,717,533 to 40,615,414 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.